[1]
|
Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia Type 1 and 2[J]. Presse Med, 2018, 47:722-731. doi: 10.1016/j.lpm.2018.03.005 |
[2]
|
Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1(MEN1)[J]. J Clin Endocrinol Metab, 2012, 97:2990-3011. doi: 10.1210/jc.2012-1230 |
[3]
|
Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome[J]. N Engl J Med, 1999, 341:635-644. doi: 10.1056/NEJM199908263410902 |
[4]
|
中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组.原发性甲状旁腺功能亢进症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志, 2014, 7:187-198. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhgzsshgkyjbzz201403003 |
[5]
|
Lairmore TC, Govednik CM, Quinn CE, et al. A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1[J]. Surgery, 2014, 156:1326-1335. doi: 10.1016/j.surg.2014.08.006 |
[6]
|
中华医学会内分泌学分会肾上腺学组.嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J].中华内分泌代谢杂志, 2016, 32:181-187. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhnfmdx201603002 |
[7]
|
邓建华, 李汉忠.嗜铬细胞瘤/副神经节瘤基因突变相关遗传综合征[J].协和医学杂志, 2015:161-165. http://www.cqvip.com/QK/70803X/201503/665023395.html |
[8]
|
Castinetti F, Qi XP, Walz MK, et al. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2:an international retrospective population-based study[J]. Lancet Oncol, 2014, 15:648-655. doi: 10.1016/S1470-2045(14)70154-8 |
[9]
|
樊华, 张玉石, 李汉忠, 等.保留肾上腺功能的腹腔镜双侧嗜铬细胞瘤切除术[J].中华内分泌外科杂志, 2017, 11:184-187. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=nfmwk201703003 |
[10]
|
Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25:567-610. doi: 10.1089/thy.2014.0335 |
[11]
|
Raue F, Frank-Raue K. Update on Multiple Endocrine Neoplasia Type 2:Focus on Medullary Thyroid Carcinoma[J]. J Endocr Soc, 2018, 2:933-943. doi: 10.1210/js.2018-00178 |
[12]
|
Krampitz GW, Norton JA. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma[J]. Cancer, 2014, 120:1920-1931. doi: 10.1002/cncr.28661 |
[13]
|
Marx SJ. Recent Topics Around Multiple Endocrine Neop-lasia Type 1[J]. J Clin Endocrinol Metab, 2018, 103:1296-1301. doi: 10.1210/jc.2017-02340 |
[14]
|
Falconi M, Eriksson B, Kaltsas G, et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Funct-ional Pancreatic Neuroendocrine Tumors[J]. Neuroendocrinology, 2016, 103:153-171. doi: 10.1159/000443171 |
[15]
|
Shah M, Goldner W, Benson A, et al. NCCN Clinical Practice Guidelines in Oncology:Neuroendocrine and Adrenal Tumors[J]. J Natl Compr Canc Netw, 2018, 16:693-702. doi: 10.6004/jnccn.2018.0056 |
[16]
|
Albers MB, Manoharan J, Bartsch DK. Contemporary surg-ical management of the Zollinger-Ellison syndrome in mul-tiple endocrine neoplasia type 1[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33:101318. doi: 10.1016/j.beem.2019.101318 |
[17]
|
Pavel M, Valle JW, Eriksson B, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms:Systemic Therapy-Biotherapy and Novel Targeted Agents[J]. Neuroendocrinology, 2017, 105:266-280. doi: 10.1159/000471880 |
[18]
|
Hicks R, Kwekkeboom D, Krenning E, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroen-docrine Neoplasia Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues[J]. Neuroendocrinology, 2017, 105:295-309. doi: 10.1159/000475526 |
[19]
|
Wu Y, Gao L, Guo X, et al. Pituitary adenomas in patients with multiple endocrine neoplasia type 1:a single-center experience in China[J]. Pituitary, 2019, 22:113-123. doi: 10.1007/s11102-019-00939-x |
[20]
|
De Laat JM, Dekkers OM, Pieterman CR, et al. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1:Results From the DutchMEN1 Study Group (DMSG)[J]. J Clin Endocrinol Metab, 2015, 100:3288-3296. doi: 10.1210/JC.2015-2015 |